Logo image of NEPH

NEPHROS INC (NEPH) Stock Fundamental Analysis

USA - Nasdaq - NASDAQ:NEPH - US6406714005 - Common Stock

5.02 USD
+0.05 (+1.01%)
Last: 12/12/2025, 8:00:01 PM
Fundamental Rating

5

Overall NEPH gets a fundamental rating of 5 out of 10. We evaluated NEPH against 130 industry peers in the Machinery industry. NEPH is in great health and has no worries on liquidiy or solvency at all, but the profibility rating is only average. While showing a medium growth rate, NEPH is valued expensive at the moment.


Dividend Valuation Growth Profitability Health

4

1. Profitability

1.1 Basic Checks

NEPH had positive earnings in the past year.
NEPH had a positive operating cash flow in the past year.
In the past 5 years NEPH reported 4 times negative net income.
In the past 5 years NEPH reported 4 times negative operating cash flow.
NEPH Yearly Net Income VS EBIT VS OCF VS FCFNEPH Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -2M -4M -6M

1.2 Ratios

The Return On Assets of NEPH (11.18%) is better than 81.54% of its industry peers.
NEPH's Return On Equity of 14.80% is fine compared to the rest of the industry. NEPH outperforms 74.62% of its industry peers.
Looking at the Return On Invested Capital, with a value of 11.15%, NEPH is in the better half of the industry, outperforming 76.15% of the companies in the same industry.
Industry RankSector Rank
ROA 11.18%
ROE 14.8%
ROIC 11.15%
ROA(3y)-26.57%
ROA(5y)-25.75%
ROE(3y)-50%
ROE(5y)-44.65%
ROIC(3y)N/A
ROIC(5y)N/A
NEPH Yearly ROA, ROE, ROICNEPH Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -100 -200 -300 -400

1.3 Margins

NEPH has a better Profit Margin (8.26%) than 66.15% of its industry peers.
The Operating Margin of NEPH (8.06%) is comparable to the rest of the industry.
Looking at the Gross Margin, with a value of 63.24%, NEPH belongs to the top of the industry, outperforming 98.46% of the companies in the same industry.
In the last couple of years the Gross Margin of NEPH has remained more or less at the same level.
Industry RankSector Rank
OM 8.06%
PM (TTM) 8.26%
GM 63.24%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y3.79%
GM growth 5Y0.91%
NEPH Yearly Profit, Operating, Gross MarginsNEPH Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50 -50 -100 -150

7

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is just above the Cost of Capital (WACC), so NEPH is still creating some value.
Compared to 1 year ago, NEPH has about the same amount of shares outstanding.
NEPH has more shares outstanding than it did 5 years ago.
The debt/assets ratio for NEPH is higher compared to a year ago.
NEPH Yearly Shares OutstandingNEPH Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2M 4M 6M 8M 10M
NEPH Yearly Total Debt VS Total AssetsNEPH Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M

2.2 Solvency

Based on the Altman-Z score of -2.80, we must say that NEPH is in the distress zone and has some risk of bankruptcy.
NEPH has a worse Altman-Z score (-2.80) than 85.38% of its industry peers.
NEPH has a debt to FCF ratio of 0.01. This is a very positive value and a sign of high solvency as it would only need 0.01 years to pay back of all of its debts.
NEPH has a Debt to FCF ratio of 0.01. This is amongst the best in the industry. NEPH outperforms 93.08% of its industry peers.
A Debt/Equity ratio of 0.00 indicates that NEPH is not too dependend on debt financing.
The Debt to Equity ratio of NEPH (0.00) is better than 85.38% of its industry peers.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0.01
Altman-Z -2.8
ROIC/WACC1.16
WACC9.64%
NEPH Yearly LT Debt VS Equity VS FCFNEPH Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5M -5M 10M

2.3 Liquidity

A Current Ratio of 4.34 indicates that NEPH has no problem at all paying its short term obligations.
NEPH has a better Current ratio (4.34) than 88.46% of its industry peers.
A Quick Ratio of 3.23 indicates that NEPH has no problem at all paying its short term obligations.
NEPH has a Quick ratio of 3.23. This is amongst the best in the industry. NEPH outperforms 90.00% of its industry peers.
Industry RankSector Rank
Current Ratio 4.34
Quick Ratio 3.23
NEPH Yearly Current Assets VS Current LiabilitesNEPH Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M

6

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 244.44% over the past year.
The Revenue has grown by 32.36% in the past year. This is a very strong growth!
NEPH shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 6.51% yearly.
EPS 1Y (TTM)244.44%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%50%
Revenue 1Y (TTM)32.36%
Revenue growth 3Y11.49%
Revenue growth 5Y6.51%
Sales Q2Q%35.42%

3.2 Future

NEPH is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 39523200.00% yearly.
NEPH is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 18.15% yearly.
EPS Next Y3233944820422206000%
EPS Next 2Y20999820744.76%
EPS Next 3Y39523200%
EPS Next 5YN/A
Revenue Next Year33.54%
Revenue Next 2Y22.44%
Revenue Next 3Y18.15%
Revenue Next 5YN/A

3.3 Evolution

The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
NEPH Yearly Revenue VS EstimatesNEPH Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 5M 10M 15M 20M
NEPH Yearly EPS VS EstimatesNEPH Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2019 2020 2021 2022 2023 2024 2025 2026 2027 0 0.2 -0.2 -0.4 -0.6

3

4. Valuation

4.1 Price/Earnings Ratio

NEPH is valuated quite expensively with a Price/Earnings ratio of 38.62.
64.62% of the companies in the same industry are cheaper than NEPH, based on the Price/Earnings ratio.
NEPH's Price/Earnings ratio indicates a valuation a bit more expensive than the S&P500 average which is at 26.56.
NEPH is valuated quite expensively with a Price/Forward Earnings ratio of 32.81.
NEPH's Price/Forward Earnings ratio is a bit more expensive when compared to the industry. NEPH is more expensive than 65.38% of the companies in the same industry.
NEPH is valuated rather expensively when we compare the Price/Forward Earnings ratio to 23.79, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 38.62
Fwd PE 32.81
NEPH Price Earnings VS Forward Price EarningsNEPH Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

73.08% of the companies in the same industry are cheaper than NEPH, based on the Enterprise Value to EBITDA ratio.
70.00% of the companies in the same industry are more expensive than NEPH, based on the Price/Free Cash Flow ratio.
Industry RankSector Rank
P/FCF 19.63
EV/EBITDA 30.38
NEPH Per share dataNEPH EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0.5 1 1.5

4.3 Compensation for Growth

NEPH's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
NEPH's earnings are expected to grow with 39523200.00% in the coming years. This may justify a more expensive valuation.
PEG (NY)0
PEG (5Y)N/A
EPS Next 2Y20999820744.76%
EPS Next 3Y39523200%

0

5. Dividend

5.1 Amount

No dividends for NEPH!.
Industry RankSector Rank
Dividend Yield 0%

NEPHROS INC

NASDAQ:NEPH (12/12/2025, 8:00:01 PM)

5.02

+0.05 (+1.01%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryMachinery
Earnings (Last)11-06 2025-11-06/amc
Earnings (Next)03-04 2026-03-04/amc
Inst Owners47.19%
Inst Owner Change3.35%
Ins Owners10.85%
Ins Owner Change0.7%
Market Cap53.36M
Revenue(TTM)17.93M
Net Income(TTM)1.48M
Analysts82.5
Price Target7.14 (42.23%)
Short Float %0.07%
Short Ratio0.09
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)212.75%
Min EPS beat(2)178.43%
Max EPS beat(2)247.06%
EPS beat(4)4
Avg EPS beat(4)450.49%
Min EPS beat(4)178.43%
Max EPS beat(4)1080.39%
EPS beat(8)6
Avg EPS beat(8)227.45%
EPS beat(12)8
Avg EPS beat(12)151.69%
EPS beat(16)10
Avg EPS beat(16)98.99%
Revenue beat(2)2
Avg Revenue beat(2)19.73%
Min Revenue beat(2)18.66%
Max Revenue beat(2)20.79%
Revenue beat(4)4
Avg Revenue beat(4)19.17%
Min Revenue beat(4)6.29%
Max Revenue beat(4)30.93%
Revenue beat(8)4
Avg Revenue beat(8)4.24%
Revenue beat(12)6
Avg Revenue beat(12)3.61%
Revenue beat(16)7
Avg Revenue beat(16)0.06%
PT rev (1m)27.27%
PT rev (3m)27.27%
EPS NQ rev (1m)200%
EPS NQ rev (3m)200%
EPS NY rev (1m)144.44%
EPS NY rev (3m)450%
Revenue NQ rev (1m)8.38%
Revenue NQ rev (3m)8.38%
Revenue NY rev (1m)7.19%
Revenue NY rev (3m)7.19%
Valuation
Industry RankSector Rank
PE 38.62
Fwd PE 32.81
P/S 2.98
P/FCF 19.63
P/OCF 19.63
P/B 5.33
P/tB 6.1
EV/EBITDA 30.38
EPS(TTM)0.13
EY2.59%
EPS(NY)0.15
Fwd EY3.05%
FCF(TTM)0.26
FCFY5.1%
OCF(TTM)0.26
OCFY5.1%
SpS1.69
BVpS0.94
TBVpS0.82
PEG (NY)0
PEG (5Y)N/A
Graham Number1.66
Profitability
Industry RankSector Rank
ROA 11.18%
ROE 14.8%
ROCE 13.4%
ROIC 11.15%
ROICexc 21.42%
ROICexgc 27.63%
OM 8.06%
PM (TTM) 8.26%
GM 63.24%
FCFM 15.16%
ROA(3y)-26.57%
ROA(5y)-25.75%
ROE(3y)-50%
ROE(5y)-44.65%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y3.79%
GM growth 5Y0.91%
F-Score7
Asset Turnover1.35
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0.01
Debt/EBITDA 0.01
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage 722.5
Cash Conversion 171.33%
Profit Quality 183.59%
Current Ratio 4.34
Quick Ratio 3.23
Altman-Z -2.8
F-Score7
WACC9.64%
ROIC/WACC1.16
Cap/Depr(3y)38.4%
Cap/Depr(5y)49.1%
Cap/Sales(3y)0.77%
Cap/Sales(5y)1.1%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)244.44%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%50%
EPS Next Y3233944820422206000%
EPS Next 2Y20999820744.76%
EPS Next 3Y39523200%
EPS Next 5YN/A
Revenue 1Y (TTM)32.36%
Revenue growth 3Y11.49%
Revenue growth 5Y6.51%
Sales Q2Q%35.42%
Revenue Next Year33.54%
Revenue Next 2Y22.44%
Revenue Next 3Y18.15%
Revenue Next 5YN/A
EBIT growth 1Y250.52%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y208.98%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y208.98%
OCF growth 3YN/A
OCF growth 5YN/A

NEPHROS INC / NEPH FAQ

What is the fundamental rating for NEPH stock?

ChartMill assigns a fundamental rating of 5 / 10 to NEPH.


What is the valuation status of NEPHROS INC (NEPH) stock?

ChartMill assigns a valuation rating of 3 / 10 to NEPHROS INC (NEPH). This can be considered as Overvalued.


Can you provide the profitability details for NEPHROS INC?

NEPHROS INC (NEPH) has a profitability rating of 4 / 10.


Can you provide the expected EPS growth for NEPH stock?

The Earnings per Share (EPS) of NEPHROS INC (NEPH) is expected to grow by 3233944820422206000% in the next year.